Double-Stranded RNA-Dependent Protein Kinase Regulates the Motility of Breast Cancer Cells

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Xu, Mei ^a   Chen, Gang ^a   Wang, Siying ^a,b   Liao, Mingjun ^a   Frank, Jacqueline A ^a   Bower, Kimberly A ^a   Zhang, Zhuo ^a   Shi, Xianglin ^a   Luo, Jia ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COFILIN; DOUBLE STRANDED RNA; LIM KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE ACTIVATED PROTEIN KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROTEIN KINASE; PROTEIN KINASE R; SERINE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL MIGRATION; CELL MOTILITY; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LAMELLIPODIUM; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ACTIN DEPOLYMERIZING FACTORS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; EIF-2 KINASE; ENZYME ACTIVATION; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIM KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 84868138734     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047721     Document Type: Article

References (43)

1. Williams BR (2001) Signal integration via PKR. Sci STKE 2001: re2. 10.1126/stke.2001.89.re2 [doi];2001/89/re2 [pii].
2. Peters GA, Dickerman B, Sen GC (2009) Biochemical analysis of PKR activation by PACT. Biochemistry 48: 7441-7447. 10.1021/bi900433y [doi].
3. Vorburger SA, Pataer A, Swisher SG, Hunt KK (2004) Genetically targeted cancer therapy: tumor destruction by PKR activation. Am J Pharmacogenomics 4: 189-198. 436 [pii].
4. Ke ZJ, Wang X, Fan Z, Luo J (2009) Ethanol promotes thiamine deficiency-induced neuronal death: involvement of double-stranded RNA-activated protein kinase. Alcohol Clin Exp Res 33: 1097-1103. ACER931 [pii];10.1111/j.1530-0277.2009.00931.x [doi].
5. Balachandran S, Barber GN, (2007) PKR in innate immunity, cancer, and viral oncolysis. Methods Mol Biol 383: 277-301.
6. Raven JF, Koromilas AE (2008) PERK and PKR: old kinases learn new tricks. Cell Cycle 7: 1146-1150. 5811 [pii].
7. Jagus R, Joshi B, Barber GN (1999) PKR, apoptosis and cancer. Int J Biochem Cell Biol 31: 123-138. S1357-2725(98)00136-8 [pii].
8. Savinova O, Joshi B, Jagus R (1999) Abnormal levels and minimal activity of the dsRNA-activated protein kinase, PKR, in breast carcinoma cells. Int J Biochem Cell Biol 31: 175-189. S1357-2725(98)00140-X [pii].
9. Haines GK, Cajulis R, Hayden R, Duda R, Talamonti M, et al. (1996) Expression of the double-stranded RNA-dependent protein kinase (p68) in human breast tissues. Tumour Biol 17: 5-12.
10. Mounir Z, Koromilas AE (2010) Uncovering the PKR pathway's potential for treatment of tumors. Future Oncol 6: 643-645. 10.2217/fon.10.45 [doi].
11. Nussbaum JM, Major M, Gunnery S (2003) Transcriptional upregulation of interferon-induced protein kinase, PKR, in breast cancer. Cancer Lett 196: 207-216. S0304383503002763 [pii].
12. Vicente-Manzanares M, Horwitz AR (2011) Cell migration: an overview. Methods Mol Biol 769: 1-24. 10.1007/978-1-61779-207-6_1 [doi].
13. Stupack DG, Cho SY, Klemke RL (2000) Molecular signaling mechanisms of cell migration and invasion. Immunol Res 21: 83-88. IR:21:2-3:83 [pii];10.1385/IR:21:2-3:83 [doi].
14. Jovceva E, Larsen MR, Waterfield MD, Baum B, Timms JF (2007) Dynamic cofilin phosphorylation in the control of lamellipodial actin homeostasis. J Cell Sci 120: 1888-1897. jcs.004366 [pii];10.1242/jcs.004366 [doi].
15. Bamburg JR (2011) Listeria monocytogenes cell invasion: a new role for cofilin in co-ordinating actin dynamics and membrane lipids. Mol Microbiol 81: 851-854. 10.1111/j.1365-2958.2011.07759.x [doi].
16. Wang W, Mouneimne G, Sidani M, Wyckoff J, Chen X, et al. (2006) The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J Cell Biol 173: 395-404. jcb.200510115 [pii];10.1083/jcb.200510115 [doi].
17. Wang W, Eddy R, Condeelis J (2007) The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 7: 429-440. nrc2148 [pii];10.1038/nrc2148 [doi].
18. Xu M, Bower KA, Wang S, Frank JA, Chen G, et al. (2010) Cyanidin-3-glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2. Mol Cancer 9: 285. 1476-4598-9-285 [pii];10.1186/1476-4598-9-285 [doi].
19. Xu M, Bower KA, Chen G, Shi X, Dong Z, et al. (2010) Ethanol enhances the interaction of breast cancer cells over-expressing ErbB2 with fibronectin. Alcohol Clin Exp Res 34: 751-760. ACER1147 [pii];10.1111/j.1530-0277.2010.01147.x [doi].
20. Wang F, Nohara K, Olivera A, Thompson EW, Spiegel S (1999) Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1-phosphate. Exp Cell Res 247: 17-28. S0014-4827(98)94327-0 [pii];10.1006/excr.1998.4327 [doi].
21. Xu M, Waters CL, Hu C, Wysolmerski RB, Vincent PA, et al. (2007) Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase. Am J Physiol Cell Physiol 293: C1309-C1318. 00014.2007 [pii];10.1152/ajpcell.00014.2007 [doi].
22. Desmarais V, Ghosh M, Eddy R, Condeelis J (2005) Cofilin takes the lead. J Cell Sci 118: 19-26. 118/1/19 [pii];10.1242/jcs.01631 [doi].
23. Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, et al.(1998) Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 393: 809-812. 10.1038/31735 [doi].
24. Kobayashi M, Nishita M, Mishima T, Ohashi K, Mizuno K (2006) MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration. EMBO J 25: 713-726. 7600973 [pii];10.1038/sj.emboj.7600973 [doi].
25. Jiang WG, (1995) Membrane ruffling of cancer cells: a parameter of tumour cell motility and invasion. Eur J Surg Oncol 21: 307-309.
26. Shir A, Friedrich I, Levitzki A, (2003) Tumor specific activation of PKR as a non-toxic modality of cancer treatment. Semin Cancer Biol 13: 309-314.
27. Garcia MA, Gil J, Ventoso I, Guerra S, Domingo E, et al. (2006) Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70: 1032-1060. 70/4/1032 [pii];10.1128/MMBR.00027-06 [doi].
28. Kim SH, Forman AP, Mathews MB, Gunnery S (2000) Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene 19: 3086-3094. 10.1038/sj.onc.1203632 [doi].
29. Lee GW, Park HS, Kim EJ, Cho YW, Kim GT, et al. (2012) Reduction of breast cancer cell migration via up-regulation of TASK-3 two-pore domain K(+) channel. Acta Physiol (Oxf) 204: 513-524. 10.1111/j.1748-1716.2011.02359.x [doi].
30. Condeelis J, Segall JE (2003) Intravital imaging of cell movement in tumours. Nat Rev Cancer 3: 921-930. 10.1038/nrc1231 [doi];nrc1231 [pii].
31. Oser M, Condeelis J (2009) The cofilin activity cycle in lamellipodia and invadopodia. J Cell Biochem 108: 1252-1262. 10.1002/jcb.22372 [doi].
32. Toshima J, Toshima JY, Takeuchi K, Mori R, Mizuno K (2001) Cofilin phosphorylation and actin reorganization activities of testicular protein kinase 2 and its predominant expression in testicular Sertoli cells. J Biol Chem 276: 31449-31458. 10.1074/jbc.M102988200 [doi];M102988200 [pii].
33. Edwards DC, Sanders LC, Bokoch GM, Gill GN (1999) Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol 1: 253-259. 10.1038/12963 [doi].
34. Ohashi K, Nagata K, Maekawa M, Ishizaki T, Narumiya S, et al. (2000) Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J Biol Chem 275: 3577-3582.
35. Bokoch GM (2003) Biology of the p21-activated kinases. Annu Rev Biochem 72: 743-781. 10.1146/annurev.biochem.72.121801.161742 [doi];121801.161742 [pii].
36. Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, et al. (1999) Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285: 895-898. 7729 [pii].
37. Zebda N, Bernard O, Bailly M, Welti S, Lawrence DS, et al. (2000) Phosphorylation of ADF/cofilin abolishes EGF-induced actin nucleation at the leading edge and subsequent lamellipod extension. J Cell Biol 151: 1119-1128.
38. Alisi A, Spaziani A, Anticoli S, Ghidinelli M, Balsano C (2008) PKR is a novel functional direct player that coordinates skeletal muscle differentiation via p38MAPK/AKT pathways. Cell Signal 20: 534-542. S0898-6568(07)00361-0 [pii];10.1016/j.cellsig.2007.11.006 [doi].
39. Silva AM, Whitmore M, Xu Z, Jiang Z, Li X, et al. (2004) Protein kinase R (PKR) interacts with and activates mitogen-activated protein kinase kinase 6 (MKK6) in response to double-stranded RNA stimulation. J Biol Chem 279: 37670-37676. 10.1074/jbc.M406554200 [doi];M406554200 [pii].
40. Goh KC, deVeer MJ, Williams BR (2000) The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J 19: 4292-4297. 10.1093/emboj/19.16.4292 [doi].
41. Iordanov MS, Paranjape JM, Zhou A, Wong J, Williams BR, et al. (2000) Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol Cell Biol 20: 617-627.
42. Spaziani A, Alisi A, Sanna D, Balsano C (2006) Role of p38 MAPK and RNA-dependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1. J Biol Chem 281: 10983-10989. M512536200 [pii];10.1074/jbc.M512536200 [doi].
43. Garcia MC, Ray DM, Lackford B, Rubino M, Olden K, et al. (2009) Arachidonic acid stimulates cell adhesion through a novel p38 MAPK-RhoA signaling pathway that involves heat shock protein 27. J Biol Chem 284: 20936-20945. M109.020271 [pii];10.1074/jbc.M109.020271 [doi].